Warby Parker Inc.

WRBY Healthcare Medical Instruments & Supplies

Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.

Revenue
+10.4%
EPS
−20.0%
Free cash flow
−30.3%

Quarter to September 2026, against a year earlier

25.79 0.29 −1.11%
Market cap
$3.2B
P/E
434×
Fwd P/E
208×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.64
Dividend safety
n/a

Warby Parker Inc. (WRBY) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Warby Parker Inc. (WRBY) trades at a P/E ratio of 434×. Over the past ten years it has ranged from 0.0× (September 2025) to 5,304× (December 2025); the current reading is higher than 85% of that period. That is above the Medical Instruments & Supplies industry median of 30.3× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 1,388× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 463× 6.82%
Jun 2026 433× (67.70%)
Mar 2026 1,342× (3.30%)
Dec 2025 1,388× (71.32%)
22 more quarters

Against its own ten years

Low 0.0× High 5,304×
Ten-year median 0.0×
Current reading's percentile 85

P/E ratio against peers

Company P/E ratio
PLSE Pulse Biosciences, Inc compare n/m
KMTS Kestra Medical Technologies, Ltd. compare n/m
AZTA Azenta, Inc. compare n/m
XRAY DENTSPLY SIRONA Inc. compare n/m
STVN Stevanato Group S.p.A. compare 22.4×
LMAT LeMaitre Vascular, Inc. compare 29.7×
ICUI ICU Medical, Inc. compare 69.3×
ATRC AtriCure, Inc. compare 199×
WRBY Warby Parker Inc. 434×
Medical Instruments & Supplies industry median 30.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on WRBY